Assignee
SQZ BIOTECHNOLOGIES CO
US·3 granted patents·19 pending applications·4 citations·filing 2016–2023
Top patents by PatentIndex Score
22 records- 0183US11692168B2Delivery of biomolecules to PBMCs to modify an immune responseSQZ BIOTECHNOLOGIES CO·Filed 2020·Granted Jul 4, 2023·3 cites·38 claims
- 0275US2023271188A1Cartridge for use in a system for delivery of a payload into a cellSQZ BIOTECHNOLOGIES CO·Filed 2023·Application pending·0 cites
- 0372US11613759B2Intracellular delivery of biomolecules to cells comprising a cell wallSQZ BIOTECHNOLOGIES CO·Filed 2016·Granted Mar 28, 2023·1 cites·25 claims
- 0468US2023357782A1Intracellular delivery of biomolecules to cells comprising a cell wallSQZ BIOTECHNOLOGIES CO·Filed 2023·Application pending·0 cites
- 0568US2023272427A1Intracellular delivery of biomolecules mediated by a surface with poresSQZ BIOTECHNOLOGIES CO·Filed 2023·Application pending·0 cites
- 0667US2022296691A1Methods for treating cancer with activating antigen carriersSQZ BIOTECHNOLOGIES CO·Filed 2021·Application pending·0 cites
- 0766US2023097861A1Intracellular delivery of complexesSQZ BIOTECHNOLOGIES CO·Filed 2022·Application pending·0 cites
- 0865US2022233677A1Methods for treating cancers with modified pbmcsSQZ BIOTECHNOLOGIES CO·Filed 2021·Application pending·0 cites
- 0964US2021363479A1Point of care system for automatically processing cellsSQZ BIOTECHNOLOGIES CO·Filed 2021·Application pending·0 cites
- 1063US11679388B2Cartridge for use in a system for delivery of a payload into a cellSQZ BIOTECHNOLOGIES CO·Filed 2020·Granted Jun 20, 2023·0 cites·24 claims
- 1162US2024228956A9DELIVERY OF BIOMOLECULES TO PBMCs TO MODIFY AN IMMUNE RESPONSESQZ BIOTECHNOLOGIES CO·Filed 2023·Application pending·0 cites
- 1257US2022203368A1Microfluidic chip having increased throughput for use in a system for delivery of a payload into a cellSQZ BIOTECHNOLOGIES CO·Filed 2021·Application pending·0 cites
- 1355US2019382796A1Intracellular delivery of biomolecules mediated by a surface with poresSQZ BIOTECHNOLOGIES CO·Filed 2016·Application pending·0 cites
- 1451US2023263879A1Methods to stimulate hla-agnostic immune responses to proteins using nucleated cellsSQZ BIOTECHNOLOGIES CO·Filed 2021·Application pending·0 cites
- 1549US2024182851A1Reprogramming of cells and uses thereofSQZ BIOTECHNOLOGIES CO·Filed 2022·Application pending·0 cites
- 1649US2022233676A1Formulations of activating antigen carriersSQZ BIOTECHNOLOGIES CO·Filed 2021·Application pending·0 cites
- 1748US2024247285A1Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereofSQZ BIOTECHNOLOGIES CO·Filed 2022·Application pending·0 cites
- 1846US2021388390A1Intracellular delivery of biomolecules to enhance antigen presenting cell functionSQZ BIOTECHNOLOGIES CO·Filed 2019·Application pending·0 cites
- 1946US2019017072A1Intracellular delivery of complexesSQZ BIOTECHNOLOGIES CO·Filed 2017·Application pending·0 cites
- 2042US2021317187A1Intracellular delivery of biomolecules to modulate antibody productionSQZ BIOTECHNOLOGIES CO·Filed 2018·Application pending·0 cites
- 2139US2022105166A1Anucleate cell-derived vaccinesSQZ BIOTECHNOLOGIES CO·Filed 2020·Application pending·0 cites
- 2236US2021138050A1Intracellular delivery of biomolecules to induce toleranceSQZ BIOTECHNOLOGIES CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SQZ BIOTECHNOLOGIES CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →